Duality of N-3 polyunsaturated fatty acids on Mcp-1 expression in vascular smooth muscle: A potential role of 4-hydroxy hexenal

Nutrients

Volumn 7, Issue 9, 2015, Pages 8112-8126

  Nagayama, Kohji ^a   Morino, Katsutaro ^a   Sekine, Osamu ^a   Nakagawa, Fumiyuki ^a,b   Ishikado, Atsushi ^a,c,d   Iwasaki, Hirotaka ^a   Okada, Takashi ^a   Tawa, Masashi ^a   Sato, Daisuke ^a   Imamura, Takeshi ^a   Nishio, Yoshihiko ^e   Ugi, Satoshi ^a   Kashiwagi, Atsunori ^f   Okamura, Tomio ^a   Maegawa, Hiroshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Osaka Laboratory JCL Bioassay Corporation   (Japan)

^c Sunstar Inc   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f Kusatsu General Hospital   (Japan)

Author keywords

4 hydroxy hexenal; Docosahexaenoic acid; Eicosapentaenoic acid; Monocyte chemotactic protein 1

Indexed keywords

HEXOBARBITAL; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; 4-HYDROXY-2-HEXENAL; ALDEHYDE; CCL2 PROTEIN, RAT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; NFE2L2 PROTEIN, RAT; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHYSIOLOGICAL PROCESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; METABOLISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; THORACIC AORTA; TIME FACTOR;

ALDEHYDES; ANIMALS; AORTA, THORACIC; CELLS, CULTURED; CHEMOKINE CCL2; CHROMATOGRAPHY, LIQUID; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EICOSAPENTAENOIC ACID; IN VITRO TECHNIQUES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-E2-RELATED FACTOR 2; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TIME FACTORS; TRANSFECTION;

EID: 84942357835     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7095381     Document Type: Article

References (35)

1. Libby, P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104, 365–372. [CrossRef] [PubMed]
2. Kromhout, D.; Bosschieter, E.B.; de Lezenne Coulander, C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 1985, 312, 1205–1209. [PubMed]
3. Iso, H.; Kobayashi, M.; Ishihara, J.; Sasaki, S.; Okada, K.; Kita, Y.; Kokubo, Y.; Tsugane, S. Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan public health center-based (JPHC) study cohort I. Circulation 2006, 113, 195–202. [CrossRef]
4. Yagi, S.; Aihara, K.I.; Fukuda, D.; Takashima, A.; Hara, T.; Hotchi, J.; Ise, T.; Yamaguchi, K.; Tobiume, T.; Iwase, T.; et al. Effects of docosahexaenoic acid on the endothelial function in patients with coronary artery disease. J. Atheroscler. Thromb. 2015, 22, 447–454. [CrossRef] [PubMed]
5. Yamada, H.; Yoshida, M.; Nakano, Y.; Suganami, T.; Satoh, N.; Mita, T.; Azuma, K.; Itoh, M.; Yamamoto, Y.; Kamei, Y.; et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 2173–2179. [CrossRef] [PubMed]
6. Matsumoto, M.; Sata, M.; Fukuda, D.; Tanaka, K.; Soma, M.; Hirata, Y.; Nagai, R. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 2008, 197, 524–533. [CrossRef] [PubMed]
7. Orr, A.W.; Hastings, N.E.; Blackman, B.R.; Wamhoff, B.R. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J. Vasc. Res. 2010, 47, 168–180.
8. Oh, D.Y.; Talukdar, S.; Bae, E.J.; Imamura, T.; Morinaga, H.; Fan, W.; Li, P.; Lu, W.J.; Watkins, S.M.; Olefsky, J.M. Gpr120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142, 687–698. [CrossRef] [PubMed]
9. Schwab, J.M.; Chiang, N.; Arita, M.; Serhan, C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447, 869–874. [CrossRef] [PubMed]
10. Ishikado, A.; Nishio, Y.; Morino, K.; Ugi, S.; Kondo, H.; Makino, T.; Kashiwagi, A.; Maegawa, H. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2010, 402, 99–104. [CrossRef] [PubMed]
11. Ishikado, A.; Morino, K.; Nishio, Y.; Nakagawa, F.; Mukose, A.; Sono, Y.; Yoshioka, N.; Kondo, K.; Sekine, O.; Yoshizaki, T.; et al. 4-hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation. PLoS ONE 2013, 8, e69415. [CrossRef] [PubMed]
12. Itoh, K.; Tong, K.I.; Yamamoto, M. Molecular mechanism activating Nrf2-keap1 pathway in regulation of adaptive response to electrophiles. Free Radic. Biol. Med. 2004, 36, 1208–1213. [CrossRef] [PubMed]
13. Wakabayashi, N.; Dinkova-Kostova, A.T.; Holtzclaw, W.D.; Kang, M.I.; Kobayashi, A.; Yamamoto, M.; Kensler, T.W.; Talalay, P. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. USA 2004, 101, 2040–2045. [CrossRef] [PubMed]
14. Kusunoki, C.; Yang, L.; Yoshizaki, T.; Nakagawa, F.; Ishikado, A.; Kondo, M.; Morino, K.; Sekine, O.; Ugi, S.; Nishio, Y.; et al. Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the Nrf-2/Ho-1 pathway in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2013, 430, 225–230. [CrossRef] [PubMed]
15. Nakagawa, F.; Morino, K.; Ugi, S.; Ishikado, A.; Kondo, K.; Sato, D.; Konno, S.; Nemoto, K.; Kusunoki, C.; Sekine, O.; et al. 4-hydroxy hexenal derived from dietary n-3 polyunsaturated fatty acids induces anti-oxidative enzyme heme oxygenase-1 in multiple organs. Biochem. Biophys. Res. Commun. 2014, 443, 991–996. [CrossRef]
16. Stulnig, G.; Frisch, M.T.; Crnkovic, S.; Stiegler, P.; Sereinigg, M.; Stacher, E.; Olschewski, H.; Olschewski, A.; Frank, S. Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells. Atherosclerosis 2013, 230, 406–413. [CrossRef] [PubMed]
17. Yang, Y.C.; Lii, C.K.; Wei, Y.L.; Li, C.C.; Lu, C.Y.; Liu, K.L.; Chen, H.W. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-_B pathways. J. Nutr. Biochem. 2013, 24, 204–212. [CrossRef] [PubMed]
18. Okamura, T.; Tawa, M.; Geddawy, A.; Shimosato, T.; Iwasaki, H.; Shintaku, H.; Yoshida, Y.; Masada, M.; Shinozaki, K.; Imamura, T. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats. J. Pharmacol. Sci. 2014, 124, 76–85. [CrossRef] [PubMed]
19. Folch, J.; Lees, M.; Stanley, G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [PubMed]
20. Obata, T.; Kashiwagi, A.; Maegawa, H.; Nishio, Y.; Ugi, S.; Hidaka, H.; Kikkawa, R. Insulin signaling and its regulation of system A amino acid uptake in cultured rat vascular smooth muscle cells. Circ. Res. 1996, 79, 1167–1176. [CrossRef] [PubMed]
21. O’Brien-Coker, I.C.; Perkins, G.; Mallet, A.I. Aldehyde analysis by high performance liquid chromatography/tandem mass spectrometry. Rapid. Commun. Mass Spectrom. 2001, 15, 920–928. [CrossRef]
22. Calder, P.C. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol. Nutr. Food Res. 2012, 56, 1073–1080. [CrossRef] [PubMed]
23. Thies, F.; Garry, J.M.; Yaqoob, P.; Rerkasem, K.; Williams, J.; Shearman, C.P.; Gallagher, P.J.; Calder, P.C.; Grimble, R.F. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomised controlled trial. Lancet 2003, 361, 477–485. [CrossRef]
24. Jeong, S.; Jing, K.; Kim, N.; Shin, S.; Kim, S.; Song, K.S.; Heo, J.Y.; Park, J.H.; Seo, K.S.; Han, J.; et al. Docosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cells. BMC Cancer 2014, 14, 481. [CrossRef] [PubMed]
25. Diep, Q.N.; Touyz, R.M.; Schiffrin, E.L. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 2000, 36, 851–855. [CrossRef] [PubMed]
26. Lee, J.Y.; Je, J.H.; Kim, D.H.; Chung, S.W.; Zou, Y.; Kim, N.D.; Yoo, M. A.; Suck Baik, H.; Yu, B.P.; Chung, H.Y. Induction of endothelial apoptosis by 4-hydroxyhexenal. Eur. J. Biochem. 2004, 271, 1339–1347. [CrossRef] [PubMed]
27. Yoo, A.R.; Koh, S.H.; Cho, G.W.; Kim, S.H. Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway. J. Atheroscler. Thromb. 2010, 17, 1009–1018. [CrossRef] [PubMed]
28. Kwak, S.M.; Myung, S.K.; Lee, Y.J.; Seo, H.G.; the Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebo-controlled trials. Arch. Intern. Med. 2012, 172, 686–694. [PubMed]
29. Dong, X.; Bi, L.; He, S.; Meng, G.; Wei, B.; Jia, S.; Liu, J. FFAs-ROS-ERK/P38 pathway plays a key role in adipocyte lipotoxicity on osteoblasts in co-culture. Biochimie 2014, 101, 123–131. [CrossRef] [PubMed]
30. Zhou, L.; Cai, X.; Han, X.; Ji, L. P38 plays an important role in glucolipotoxicity-induced apoptosis in INS-1 cells. J. Diabetes Res. 2014, 2014. [CrossRef] [PubMed]
31. Anderson, E.J.; Thayne, K.; Harris, M.; Carraway, K.; Shaikh, S.R. Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acids. Biochem. J. 2012, 441, 359–366. [CrossRef] [PubMed]
32. Gladine, C.; Roy, N.C.; Rigaudière, J.P.; Laillet, B.; da Silva, G.; Joly, C.; Pujos-Guillot, E.; Morio, B.; Feillet-Coudray, C.; McNabb, W.C.; et al. Increasing intake of long-chain n-3 PUFA enhances lipoperoxidation and modulates hepatic gene expression in a dose-dependent manner. Br. J. Nutr. 2012, 107, 1254–1273. [CrossRef] [PubMed]
33. Calzada, C.; Colas, R.; Guillot, N.; Guichardant, M.; Laville, M.; Véricel, E.; Lagarde, M. Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men. Atherosclerosis 2010, 208, 467–472. [CrossRef] [PubMed]
34. Kondo, K.; Morino, K.; Nishio, Y.; Kondo, M.; Nakao, K.; Nakagawa, F.; Ishikado, A.; Sekine, O.; Yoshizaki, T.; Kashiwagi, A.; et al. A fish-based diet intervention improves endothelial function in postmenopausal women with type 2 diabetes mellitus: A randomized crossover trial. Metabolism 2014, 63, 930–940. [CrossRef] [PubMed]
35. Chen, D.Z.; Auborn, K. Fish oil constituent docosahexa-enoic acid selectively inhibits growth of human papillomavirus immortalized keratinocytes. Carcinogenesis 1999, 20, 249–254. [CrossRef] [PubMed]